English
Home > Products > 1-Phenylmethyl-5-phenyl-barbituric

China 1-Phenylmethyl-5-phenyl-barbituric Factory

We follow our enterprise spirit of "Quality, Efficiency, Innovation and Integrity". We aim to create much more worth for our buyers with our abundant resources, highly developed machinery, experienced workers and great providers for 1-Phenylmethyl-5-phenyl-barbituric,CAS NO 72846-00-5,72846-00-5,5-phenyl-barbituric acid, Our enterprise warmly welcome close friends from everywhere in the environment to go to, examine and negotiate organization.
1-Phenylmethyl-5-phenyl-barbituric, Our factory is equipped with complete facility in 10000 square meters, which makes us be able to satisfy the producing and sales for most auto part products and solutions. Our advantage is full category, high quality and competitive price! Based on that, our goods win a high admiration both at home and abroad.

Related Products

Hot Products

  • Ellagic acid

    Ellagic acid

    Product Name:Ellagic acid
    Molecular Formula:C14H6O8
    Molecular Weight;302.19
    CAS Registry Number;476-66-4
  • Hydriodic acid

    Hydriodic acid

    Product Name:Hydriodic acid
    Molecular Formula:HI
    Molecular Weight:127.91
    CAS Registry Number:10034-85-2
  • Betamethasone

    Betamethasone

    Product Name:Betamethasone
    Molecular Formula:C22H29FO5
    Molecular Weight;392.47
    CAS Registry Number;378-44-9
  • Ceftibuten

    Ceftibuten

    Product Name:Ceftibuten
    Molecular Formula:C15H14N4O6S2
    Molecular Weight;410.42
    CAS Registry Number;97519-39-6
  • 9,9-Dimethyl-9H-fluorene

    9,9-Dimethyl-9H-fluorene

    Product Name:9,9-Dimethyl-9H-fluorene
    Molecular Formula:C15H14
    Molecular Weight:194.27
    CAS Registry Number:4569-45-3
  • 1-(4-Nitrophenyl)-2-Piperidinone

    1-(4-Nitrophenyl)-2-Piperidinone

    Product Name:1-(4-Nitrophenyl)-2-piperidinone
    Molecular Formula:C11H12N2O3
    Molecular Weight:220.22
    CAS Registry Number:38560-30-4
  • Related Blog
  • Reviews

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept